Skip to content
value.today

Axonics Modulation Technologies, Inc.

🇺🇸 Irvine, California, USATechnologyFounded 2012

Formerly American Restorative Medicine, Inc.

Total raised
$124 M
4 rounds on record
Latest round
$55 M
Apr 2017
First round on record
Mar 2014
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Axonics Modulation Technologies, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2017$55 MNo. 4$50 to $250 million

Axonics Modulation Technologies, Inc.: Raise no. 4, Apr 2017

Investors in this round

17 investors had bought by the notice of Apr 12, 2018: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 15 investors are named for Axonics Modulation Technologies, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$55 M of $55 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dan L. Dearen · Executive Officer
  • Michael L. Williamson · Executive Officer
  • Raymond W. Cohen · Executive Officer, Director
  • Erik L. Amble · Director
  • Geoff L. Pardo · Director
  • John L. Petrovich · Director
  • Juliet Tammenoms Bakker · Director
  • Raphael L. Wisniewski · Director
  • Shahzad L. Malik · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Raymond W. Cohen, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Apr 12, 2018. Read the notice at the SEC.

equitySEC
Dec 2015$39 MNo. 3$10 to $50 million

Axonics Modulation Technologies, Inc.: Raise no. 3, Dec 2015

Investors in this round

14 investors had bought by the notice of Dec 21, 2015: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 15 investors are named for Axonics Modulation Technologies, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$39 M of $39 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dan L. Dearen · Executive Officer
  • Michael L. Williamson · Executive Officer
  • Raymond W. Cohen · Executive Officer, Director
  • Barry L. Keenan · Director
  • Darren L. Cai · Director
  • Erik L. Amble · Director
  • John L. Petrovich · Director
  • Raphael L. Wisniewski · Director
  • Shahzad L. Malik · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Williamson, Sr. Vice President. Source: SEC Form D, newest notice filed Dec 21, 2015. Read the notice at the SEC.

equitySEC
Apr 2015$17 MNo. 2$10 to $50 million

Axonics Modulation Technologies, Inc.: Raise no. 2, Apr 2015

Investors in this round

8 investors had bought by the notice of Apr 29, 2015: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 15 investors are named for Axonics Modulation Technologies, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$17 M of $17 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$910,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dan L. Dearen · Executive Officer
  • Michael L. Williamson · Executive Officer
  • Raymond W. Cohen · Executive Officer, Director
  • Darren L. Cai · Director
  • David L. Hankin · Director
  • Erik L. Amble · Director
  • John L. Petrovich · Director
  • Raphael L. Wisniewski · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Williamson, Sr. Vice President and Secretary. Source: SEC Form D, newest notice filed Apr 29, 2015. Read the notice at the SEC.

equitySEC
Mar 2014$14 MNo. 1$10 to $50 million

Axonics Modulation Technologies, Inc.: Raise no. 1, Mar 2014

Investors in this round

6 investors had bought by the notice of Mar 31, 2014: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 15 investors are named for Axonics Modulation Technologies, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$14 M of $35 M offered; $22 M still to sell
Smallest investment taken
$200,000
What was sold
equity, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$800,000 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dan L. Dearen · Executive Officer
  • Michael V. Williamson · Executive Officer
  • Raymond W. Cohen · Executive Officer, Director
  • David V. Hankin · Director
  • John G. Petrovich · Director
  • Raphael V. Wisniewski · Director
  • Robert V. Guezuraga · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael V. Williamson, Secretary. Source: SEC Form D, newest notice filed Mar 31, 2014. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Axonics Modulation Technologies, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2018).

    SEC Form D · Apr 2018

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Apr 2018

That is all the official record says: Axonics Modulation Technologies, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

15 named in official filings. Open an investor to see everything it has backed.

Investors in Axonics Modulation Technologies, Inc.
InvestorKindAmountRoundRoleSource
Advent Life Sciences Fund II LPFund or asset managernot statednot statedHeld Series B-2 and C preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Advent Life Sciences LLPFund or asset managernot statednot statedHeld Series B-2 and C preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Alfred E. Mann Foundation for Scientific ResearchOthernot statednot statedHeld Series A and B-1 preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Andera PartnersFund or asset managernot statednot statedHeld Series A, B-1, B-2 and C preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Cormorant Asset Management, LPFund or asset managernot statednot statedHeld Series B-2 and C preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Cormorant Global Healthcare Master Fund, LPFund or asset managernot statednot statedHeld Series B-2 and C preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Cormorant Private Healthcare Fund I, LPFund or asset managernot statednot statedHeld Series B-2 and C preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Gilde Healthcare Holding B.V.Othernot statednot statedHeld Series C preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Gilde Healthcare IV Management B.V.Fund or asset managernot statednot statedHeld Series C preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Guangqiang JiangPersonnot statednot statedHeld Series B-1 preferred stock (Form 3, 2018)SEC Form 3
Longitude Capital Partners III, LLCFund or asset managernot statednot statedHeld Series C preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Longitude Venture Partners III, L.P.Venture capitalnot statednot statedHeld Series C preferred stock, 10% owner (Form 3, 2018)SEC Form 3
NeoMed Innovation V L.P.Fund or asset managernot statednot statedHeld Series A, B-1, B-2 and C preferred stock, 10% owner (Form 3, 2018)SEC Form 3
NeoMed Innovation V LtdCompanynot statednot statedHeld Series A, B-1, B-2 and C preferred stock, 10% owner (Form 3, 2018)SEC Form 3
Zac & Cloud Holdings LTDCompanynot statednot statedHeld Series A, B-1 and B-2 preferred stock, 10% owner (Form 3, 2018)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 17 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Axonics Modulation Technologies, Inc.
NameRoleNamed in
Dan L. DearenExecutive officerApr 2018
Michael L. WilliamsonExecutive officerApr 2018
Raymond W. CohenExecutive officerApr 2018
Michael V. WilliamsonExecutive officerMar 2014
Erik L. AmbleDirectorApr 2018
Geoff L. PardoDirectorApr 2018
John L. PetrovichDirectorApr 2018
Juliet Tammenoms BakkerDirectorApr 2018
Raphael L. WisniewskiDirectorApr 2018
Raymond W. CohenDirectorApr 2018
Shahzad L. MalikDirectorApr 2018
Darren L. CaiDirectorMay 2017
Farah L. BoroomandDirectorMay 2017
Barry L. KeenanDirectorDec 2015
David L. HankinDirectorApr 2015
David V. HankinDirectorMar 2014
John G. PetrovichDirectorMar 2014
Raphael V. WisniewskiDirectorMar 2014
Robert V. GuezuragaDirectorMar 2014